Business Development

Seeking Partners in Innovation

The Business Development & Strategy group works to commercialize intellectual property generated by Fred Hutch researchers so our discoveries and innovations can contribute to better cancer care at the clinic level. We seek industry partners who share our drive to innovate, collaborate and accelerate development of new inventions and approaches. We also cultivate partnerships with philanthropic supporters, research colleagues and policymakers to extend the reach of our scientific advances.

Our areas of focus include:

  • Blood stem cell transplantation and immunotherapy
  • Cancer risk factors and causes, prevention and treatment outcomes
  • Vaccine development and virus-associated cancers
  • Molecular underpinnings of cancer
  • Tumor-specific translational research
Featured technology

Universal Gene Delivery Platform for Targeting of Hematopoietic Stem Cells

Our scientists have developed a novel technique that delivers engineered genes into blood stem cells by using nontoxic gold nanoparticles as couriers.

Learn more All available technologies

Recent Startup Successes

All spinouts & startups
Adaptive Biotechnologies

Adaptive Biotechnologies

Juno Therapeutics

Juno Therapeutics

Faraday Pharmaceuticals

Faraday Pharmaceuticals

Adaptive Biotechnologies

Founded in 2009 by two young Fred Hutch researchers — computational biologist Harlan Robins and molecular biologist and geneticist Chris Carlson — Adaptive Biotechnologies has quickly become a leader in high-throughput DNA sequencing of immune system T cells and B cells for research and diagnostic purposes. In 2018, Adaptive announced a partnership with Microsoft Research to combine its sequencing technology with machine learning and artificial intelligence, with the goal of mapping the entire human immune system and eventually developing a universal blood test to detect any diseases a person’s body may be fighting.

Adaptive Biotechnologies

Adaptive Biotechnologies

Adaptive Biotechnologies

Founded in 2009 by two young Fred Hutch researchers — computational biologist Harlan Robins and molecular biologist and geneticist Chris Carlson — Adaptive Biotechnologies has quickly become a leader in high-throughput DNA sequencing of immune system T cells and B cells for research and diagnostic purposes. In 2018, Adaptive announced a partnership with Microsoft Research to combine its sequencing technology with machine learning and artificial intelligence, with the goal of mapping the entire human immune system and eventually developing a universal blood test to detect any diseases a person’s body may be fighting.

Juno Therapeutics

Juno Therapeutics

Juno Therapeutics

Juno Therapeutics was founded in 2013 as a collaboration between Fred Hutch, Memorial Sloan-Kettering Cancer Research Center and Seattle Children’s Research Institute, combining cutting-edge immunotherapy expertise from all three institutions. With $120 million in Series A private investment funding, Juno was one of the largest biotech launches in history. Now a Celgene company, Juno focuses on developing innovative T-cell therapies to treat a broad range of cancers, with the goal of less long-term toxicity than current chemotherapy treatments and the potential to cure even patients with widespread disease.
Faraday Pharmaceuticals

Faraday Pharmaceuticals

Faraday Pharmaceuticals

Founded in 2014, Faraday Pharmaceuticals is advancing pioneering research from Mark Roth’s lab at Fred Hutch on how salts can temporarily shift a person’s metabolism to protect against injury when blood rushes back to a damaged area after circulation has stopped — such as after a heart attack. Roth, a 2007 MacArthur Foundation “genius” grant recipient, has served as president of the company and a member of the board of directors since its founding.
Featured Partnership

LAB591

This collaboration between Fred Hutch and two European partners — Hamburg-based drug discovery and development company Evotec SE and London-based venture capital firm Arix Bioscience — aims to speed up the development of new cancer and infectious disease drugs by providing funding and expertise for the formation of new companies based on discoveries made at Fred Hutch and elsewhere. Launched in 2018, the partnership is administered by the three partner institutions, and all projects are selected by a joint steering committee.

Learn more Other partnerships

Partnering Events & Conferences

All business development events
Search and Filter
Date Range Date Range

Upcoming Events

Jan 13
Jan 13

J.P. Morgan Healthcare Conference (2020)

This is a multi-day event, please click for details
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
Location San Francisco, CA
Host J.P. Morgan
Jan 20
Jan 20

Phacilitate Leaders World Stem Cell Summit (2020)

This is a multi-day event, please click for details
Phacilitate Leaders World and the World Stem Cell Summit will once again be co-located, resulting in the biggest event in its 15-year history and one that incorporates the entire advanced therapies ecosystem. By bringing these two events under one roof, the summit provides a platform to build new partnerships, empower future leaders and evolve advanced therapies.
Location Miami, FL
Contact 206.667.4304 or partnering@fredhutch.org
Host Phacilitate Leaders World and World Stem Cell Summit
March 23
March 23

BIO-Europe Spring (2020)

This is a multi-day event, please click for details
Engage with the right partners at Europe’s largest springtime biotech partnering event. BIO-Europe Spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.
Location Paris, France
Contact 206.667.4304 or partnering@fredhutch.org
Host EBD Group
April 14
April 14

Cell & Gene Meeting on the Med (2020)

This is a multi-day event, please click for details
The Cell & Gene Meeting on the Mediterranean is a conference bringing together the entire cell and gene therapy community from Europe and beyond. The event covers a wide range of commercialization topics, from market access and regulatory issues to manufacturing and financing the sector.
Location Barcelona, Spain
Contact 206.667.4304 or partnering@fredhutch.org
Host Alliance for Regenerative Medicine
April 24
April 24

AACR Annual Meeting (2020)

This is a multi-day event, please click for details
The American Association for Cancer Research (AACR) Annual Meeting program covers the latest discoveries across the spectrum of cancer research — from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy — and highlights the work of the best minds in research and medicine from institutions all over the world.
Location San Diego, CA
Contact 206.667.4304 or partnering@fredhutch.org
Host American Association for Cancer Research
May 29
May 29

Immuno-Oncology: BD&L and Investment Forum (2020)

The 6th Annual Immuno-Oncology BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment.
Location Chicago, IL
Contact 206.667.4304 or partnering@fredhutch.org
Host Sachs Associates
May 29
May 29

ASCO Annual Meeting (2020)

This is a multi-day event, please click for details
The American Society of Clinical Oncology (ASCO) offers premier scientific events for oncology professionals, patient advocates, industry representatives, and major media outlets worldwide.
Location Chicago, IL
Contact 206.667.4304 or partnering@fredhutch.org
Host American Society of Clinical Oncolgy
June 8
June 8

BIO International Convention (2020)

This is a multi-day event, please click for details
The BIO International Convention represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
Location San Diego, CA
Contact 206.667.4304 or partnering@fredhutch.org
Host Biotechnology Innovation Organization

Your search for "" did not match any of our events. Please try another event term or combination of terms and filters.

Careers in Business Development

View jobs

Latest Business Development News

All business development news >
Eight promising projects win Evergreen Fund grants to promote commercialization of research A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program August 2, 2019
Seattle Times' Pacific NW Magazine profiles Fred Hutch Seattle Times’ Sunday feature looks at the melding of expertise, drive and technology making new cures possible May 17, 2018
A focus on partnerships at Hutch/Merck summit Research on the immune system aims to stop infectious diseases and cancer May 11, 2018
Scientists-turned-entrepreneurs share lessons learned launching startups From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found March 26, 2018

Mailing Address

Fred Hutchinson Cancer Research Center
Business Development & Strategy
Mail Stop J2-110
PO Box 19024
Seattle, WA 98109-1024

Material transfer agreements or confidential disclosure agreements: MTA@fredhutch.org

Phone: 206.667.4304

Location & Parking

823 Yale Ave. N.
Seattle, WA 98109

Visitors can park in the visitor parking lot adjacent to the Yale Building.

Campus map

Last Modified, November 13, 2019